Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 3
1996 10
1997 4
1998 1
1999 2
2000 3
2001 6
2002 2
2004 6
2005 7
2006 19
2007 43
2008 58
2009 42
2010 30
2011 29
2012 24
2013 16
2014 18
2015 24
2016 35
2017 30
2018 26
2019 32
2020 68
2021 60
2022 63
2023 43
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

638 results

Results by year

Filters applied: . Clear all
Page 1
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Grønbæk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. Eslam M, et al. Among authors: targher g. J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278004 Free article. Review.
NAFLD: a multisystem disease.
Byrne CD, Targher G. Byrne CD, et al. Among authors: targher g. J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012. J Hepatol. 2015. PMID: 25920090 Free article. Review.
NASH drug treatment development: challenges and lessons.
Tilg H, Byrne CD, Targher G. Tilg H, et al. Among authors: targher g. Lancet Gastroenterol Hepatol. 2023 Oct;8(10):943-954. doi: 10.1016/S2468-1253(23)00159-0. Epub 2023 Aug 16. Lancet Gastroenterol Hepatol. 2023. PMID: 37597527 Review.
Current status and future trends of the global burden of MASLD.
Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Miao L, et al. Among authors: targher g. Trends Endocrinol Metab. 2024 Aug;35(8):697-707. doi: 10.1016/j.tem.2024.02.007. Epub 2024 Feb 29. Trends Endocrinol Metab. 2024. PMID: 38429161 Review.
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review.
Mantovani A, Byrne CD, Targher G. Mantovani A, et al. Among authors: targher g. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):367-378. doi: 10.1016/S2468-1253(21)00261-2. Epub 2022 Jan 12. Lancet Gastroenterol Hepatol. 2022. PMID: 35030323 Review.
638 results